Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 8, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

CD30+ lymphoproliferative disorders

Laurence de Leval, Philippe Gaulard

    Haematologica
    |October 2, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Murine Model of CD40-activation of B cells
    12:24

    Murine Model of CD40-activation of B cells

    Published on: March 5, 2010

    Related Experiment Videos

    Last Updated: Jun 8, 2026

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
    10:21

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

    Published on: February 21, 2018

    Murine Model of CD40-activation of B cells
    12:24

    Murine Model of CD40-activation of B cells

    Published on: March 5, 2010

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genomic loss of MLH1/PMS2 loci defines a mismatch repair deficient subgroup in monomorphic epitheliotropic intestinal T-cell lymphoma.

    Blood cancer journal·2026
    Same author

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same author

    Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.

    Leukemia·2026
    Same author

    Secondary <i>BRAF</i>-mutated histiocytic/dendritic cell sarcoma transdifferentiated from follicular lymphoma with prolonged response to BRAF/MEK inhibition and subsequent evolution to high-grade B-cell lymphoma.

    Journal of clinical pathology·2026
    Same author

    Intrasinusoidal ALK-positive anaplastic large cell lymphoma.

    Journal of hematopathology·2025
    Same author

    Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

    Leukemia·2025
    Same journal

    Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

    Haematologica·2026
    Same journal

    Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

    Haematologica·2026
    Same journal

    Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

    Haematologica·2026
    Same journal

    Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

    Haematologica·2026
    Same journal

    Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

    Haematologica·2026
    Same journal

    A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

    Haematologica·2026
    See all related articles